Svetlana Azova, MD
Assistant Director of Quality Improvement, Division of Endocrinology; Attending Physician, Division of Endocrinology
Instructor of Pediatrics, Harvard Medical School
Image
Svetlana Azova, MD
Assistant Director of Quality Improvement, Division of Endocrinology; Attending Physician, Division of Endocrinology
Instructor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
Macaulay Honors College at Hunter College
2010
New York
NY
Medical School
New York University School Of Medicine
2014
New York
NY
Internship
Icahn School of Medicine at Mount Sinai
2015
New York
NY
Residency
Icahn School of Medicine at Mount Sinai
2018
New York
NY
Fellowship
Boston Children's Hospital
2021
Boston
MA
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Endocrinology)
Publications
Patient Characteristics Associated With Annual Nutrition Visits in Children With Type 1 Diabetes. View Abstract
Sociodemographic inequities and use of hybrid closed-loop systems associated with obesity in youth with type 1 diabetes. View Abstract
Using Quality Improvement to Design and Evaluate an Outpatient Day Treatment Pathway for Pediatric Patients with Diabetes Mellitus Requiring Insulin Initiation. View Abstract
Non-canonical Wnt signaling triggered by WNT2B drives adrenal aldosterone production. View Abstract
Increased Use of Hyperosmolar Therapy for Suspected Clinically Apparent Brain Injury in Pediatric Patients with Diabetic Ketoacidosis during the Peak of the COVID-19 Pandemic. View Abstract
Novel variants in KAT6B spectrum of disorders expand our knowledge of clinical manifestations and molecular mechanisms. View Abstract
Assessment of Pediatric Resident Knowledge and Comfort in Addressing Childhood Obesity in Clinical Practice. View Abstract
Precocious sexual development in a male toddler caused by unrecognized transdermal exposure to testosterone: case report and review of the literature. View Abstract
Novel variants in the stem cell niche factor WNT2B define the disease phenotype as a congenital enteropathy with ocular dysgenesis. View Abstract
Carbohydrate restriction for diabetes: rediscovering centuries-old wisdom. View Abstract
Graves' disease in a five-month-old boy with an unusual treatment course. View Abstract
Brain injury in children with diabetic ketoacidosis: Review of the literature and a proposed pathophysiologic pathway for the development of cerebral edema. View Abstract
New-Onset Psychosis in an Adolescent with Wilson's Disease. View Abstract
Negative Symptoms in a Depressed Teen? Primary Hyperparathyroidism and its Psychiatric Manifestations. View Abstract
Cerebral perfusion in insulin resistance and type 2 diabetes. View Abstract
[Alveolar phagocytosis and the experimental pathogenic action of dusts of the new types of fiber glass]. View Abstract
[The dust factor in the production of new types of glass fibers]. View Abstract
[Changes in blood and porphyrin metabolism during exposure to optical glass fiber dust (experimental data)]. View Abstract